The meeting brought together partners from across the consortium for several days of exchanges, updates, and forward planning, providing a valuable opportunity to reflect on progress and align on the next steps.

This General Assembly was particularly significant as it marked the first full consortium meeting after the project reached its halfway point. Discussions highlighted a clear sense of momentum: scientific work is advancing rapidly and the project’s findings are becoming increasingly mature and consolidated. Partners shared progress across activities, discussed emerging results, and explored how upcoming work will build on the foundations established so far.

Looking ahead, the coming months will be an important phase for FLAVIVACCINE, with several key updates expected as new results are generated and prepared for broader communication and dissemination.

A warm thank you to CEA for the excellent organisation of the General Assembly and for hosting the consortium so generously in Fontenay-aux-Roses.